1 | (CDP6038 | - | - | - | - | [1] 46 46 |
2 | 2-CdA | [1] Cladribine Cladribine (Synonym: 2-CdA) | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
3 | 2-CdA, 2-chloro-2'-deoxy-beta-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
4 | 2-CdA, 2-chloro-2'-deoxy-ß-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
5 | 2-CdA, 2-chloro-2?-deoxy-beta-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
6 | 2-CdA, 2-chloro-2?-deoxy-ß-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
7 | 2-CdA, 2-chloro-2’-deoxy-beta-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
8 | 2-CdA, 2-chloro-2’-deoxy-ß-D-adenosine | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
9 | 2-chloro-2'-deoxy-beta-D-adenosine (2-CdA) | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
10 | 2-chloro-2'-deoxy-ß-D-adenosine (2-CdA) | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
11 | 2-chloro-2'-deoxyadenosine (2-CdA) | [1] Cladribine Cladribine (Synonym: 2-CdA) | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
12 | 2-chloro-2’-deoxy-beta-D-adenosine (2-CdA) | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
13 | 2-chloro-2’-deoxy-ß-D-adenosine (2-CdA) | [2] Adenosine Adenosine, Cladribine (Synonym: 2-CdA) | [2] D00045
D00045
,
D01370
| [5] ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 | [17] Alcoholism Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
14 | 2-chloro-2’-deoxyadenosine (2-CdA) | [1] Cladribine Cladribine (Synonym: 2-CdA) | [1] D01370
D01370
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 |
15 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | [1] Agalsidase alfa Agalsidase alfa | [1] D02784
D02784
| [1] GLA GLA 💬 | [6] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1] 19 19 |
16 | ALLO-ASC-CD | - | - | - | - | [1] 96 96 |
17 | Anti CD3 monoclonal antibody | - | - | - | - | [1] 97 97 |
18 | Anti-CD19-CAR-T cells | - | - | - | - | [1] 49 49 |
19 | Anti-CD20 B cell depletion with Truxima | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 |
20 | Anti-CD20 small modular immunopharmaceutical, WYE-400087 | - | - | - | - | [1] 46 46 |
21 | Anti-CD25 Humanized Monoclonal Antibody | - | - | - | - | [1] 13 13 |
22 | Anti-CD28dAb | - | - | - | - | [3] 49 49, 53, 160 |
23 | Anti-CD3 | [1] Muromonab Muromonab (Synonym: Anti-CD3) | [1] D05092
D05092
(Name: Muromonab-CD3) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 |
24 | Anti-CD3 Monoclonal antibody | [1] Muromonab Muromonab (Synonym: Anti-CD3) | [1] D05092
D05092
(Name: Muromonab-CD3) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [2] 96 96, 97 |
25 | Anti-CD40L | [1] Toralizumab Toralizumab (Synonym: Anti-CD40L) | [1] D06193
D06193
| [1] CD40LG CD40LG 💬 | [14] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | [1] 63 63 |
26 | Anti-CD40LdAb | - | - | - | - | [1] 63 63 |
27 | Anti-CD45 | - | - | - | - | [3] 60 60, 65, 285 |
28 | Anti-CD52 monoclonal antibody | - | - | - | - | [1] 13 13 |
29 | AP-CD/LD | - | - | - | - | [1] 6 6 |
30 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | [3] 49 49, 51, 53 |
31 | Autologous CD34+ cell transduced with G2SCID vector | - | - | - | - | [1] 65 65 |
32 | AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 |
33 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | [1] 19 19 |
34 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | [1] 19 19 |
35 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA | - | - | - | - | [1] 20 20 |
36 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | [1] 65 65 |
37 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | [1] 65 65 |
38 | Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene | - | - | - | - | [1] 65 65 |
39 | AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR | - | - | - | - | [1] 65 65 |
40 | Autologous CD34+HPC transplantation (HSCT) | - | - | - | - | [1] 49 49 |
41 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | [1] 96 96 |
42 | Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope | - | - | - | - | [1] 13 13 |
43 | Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA | - | - | - | - | [1] 20 20 |
44 | Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells | - | - | - | - | [1] 51 51 |
45 | BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester | [2] Bardoxolone Bardoxolone, Bardoxolone methyl | [2] D09584
D09584
,
D09585
| - | - | [1] 86 86 |
46 | Biologic: IC14 (monoclonal antibody against human CD14) | - | - | - | - | [1] 2 2 |
47 | Blinded CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid (Synonym: CDCA) | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
48 | BT061 (CD4 monoclonal antibody) | - | - | - | - | [1] 46 46 |
49 | CARBIDOPA (CD) | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
50 | CD | - | - | - | - | [7] 6 6, 13, 46, 51, 96, 97, 265 |
51 | CD-4 guided therapy interruption | - | - | - | - | [1] 265 265 |
52 | CD-C-Food | - | - | - | - | [1] 96 96 |
53 | CD-LD CR | - | - | - | - | [1] 6 6 |
54 | CD-LD IR | - | - | - | - | [1] 6 6 |
55 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | [1] 11 11 |
56 | CD19/BCMA CAR T-cells | - | - | - | - | [2] 16 16, 61 |
57 | CD3-depleted hematopoietic cell transplantation | - | - | - | - | [1] 60 60 |
58 | CD3/CD19 depleted leukocytes | - | - | - | - | [1] 284 284 |
59 | CD3/CD19 neg allogeneic BMT | - | - | - | - | [1] 65 65 |
60 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | [1] 65 65 |
61 | CD3/CD19 negative hematopoietic stem cells | - | - | - | - | [1] 85 85 |
62 | CD34 selected autologous hematopoietic cells | - | - | - | - | [1] 51 51 |
63 | CD34 selected haploidentical PBSCT | - | - | - | - | [1] 285 285 |
64 | CD34 Stem Cell Selection Therapy | - | - | - | - | [3] 60 60, 65, 284 |
65 | CD34+ | - | - | - | - | [1] 65 65 |
66 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | [1] 90 90 |
67 | CD34+ CELLS | - | - | - | - | [1] 285 285 |
68 | CD34+ cells transduced with ADA retrovir | - | - | - | - | [1] 65 65 |
69 | CD34+ enriched, T Cell Depleted donor stem cell product | - | - | - | - | [1] 326 326 |
70 | CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 |
71 | CD34+ Peripheral Blood Stem Cell Reinfusion | - | - | - | - | [1] 49 49 |
72 | CD34+ selected cells | - | - | - | - | [1] 285 285 |
73 | CD34+CELLS | - | - | - | - | [2] 65 65, 285 |
74 | CD34+SC | - | - | - | - | [1] 51 51 |
75 | CD3±CD19 depleted hematopoietic stem cell transplantation | - | - | - | - | [1] 60 60 |
76 | CD45RA depleted leukocytes | - | - | - | - | [1] 284 284 |
77 | CD45RA-depleted DLI | - | - | - | - | [1] 60 60 |
78 | CD62L- Tem | - | - | - | - | [1] 60 60 |
79 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 |
80 | CDCA | [1] Chenodeoxycholic acid Chenodeoxycholic acid (Synonym: CDCA) | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
81 | CDCA Weight-Based Dose TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid (Synonym: CDCA) | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
82 | CDMARD | - | - | - | - | [1] 46 46 |
83 | CDNF | - | - | - | - | [1] 6 6 |
84 | CDP | - | - | - | - | [1] 46 46 |
85 | CDP 6038 SC | - | - | - | - | [1] 46 46 |
86 | CDP3194 | - | - | - | - | [1] 49 49 |
87 | CDP323 | [1] CDP323 CDP323 | - | - | - | [1] 13 13 |
88 | CDP6038 | - | - | - | - | [2] 46 46, 96 |
89 | CDP7657 | - | - | - | - | [1] 49 49 |
90 | CDP870 | - | - | - | - | [3] 46 46, 96, 271 |
91 | CDP870 100mg | - | - | - | - | [1] 46 46 |
92 | CDP870 200mg | - | - | - | - | [1] 46 46 |
93 | CDP870 400mg | - | - | - | - | [1] 46 46 |
94 | CDP870 Fab'-PEG | - | - | - | - | [1] 46 46 |
95 | CDX | - | - | - | - | [2] 222 222, 240 |
96 | CDX 6114 | - | - | - | - | [1] 240 240 |
97 | CDX-1135 | - | - | - | - | [1] 222 222 |
98 | CDZ173 | - | - | - | - | [2] 53 53, 65 |
99 | Cell processing for TCRabeta+/CD19+ depletion | - | - | - | - | [1] 65 65 |
100 | Cell processing for TCRaß+/CD19+ depletion | - | - | - | - | [1] 65 65 |
101 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 |
102 | Certolizumab pegol (CDP870) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 |
103 | Certolizumab pegol (CDP870, CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
104 | Certolizumab pegol (CDP870, tradename Cimzia) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
105 | Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg) | [1] Certolizumab pegol Certolizumab pegol | [1] D03441
D03441
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
106 | Chimeric human/mouse anti-CD-20 monoclonal antibody | - | - | - | - | [1] 46 46 |
107 | CHX A-DTPA anti-CD66 antibody | [1] Pentetic acid Pentetic acid | [1] D05422
D05422
| - | - | [1] 28 28 |
108 | CHX-A-DTPA-Anti-CD66 | [1] Pentetic acid Pentetic acid | [1] D05422
D05422
| - | - | [1] 28 28 |
109 | CliniMACS® CD34 Reagent System cell sorter device | - | - | - | - | [1] 65 65 |
110 | Combination of a single dose anti-CD20 antibody and bortezomib | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 61 61 |
111 | Companion diagnostic ( CDx) | - | - | - | - | [1] 51 51 |
112 | Companion diagnostic (CDx) | - | - | - | - | [1] 96 96 |
113 | Companion Diagnostic (CDx) Testing | - | - | - | - | [1] 97 97 |
114 | Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 |
115 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 |
116 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
117 | Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
118 | Cytolytic CD4+ T cells | - | - | - | - | [1] 13 13 |
119 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | [1] 62 62 |
120 | D-methylphenidate (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
121 | Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) | [1] Daclizumab Daclizumab | [1] D03639
D03639
| [1] IL2RA IL2RA 💬 | [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
122 | Depletion in CD45RA graft donor | - | - | - | - | [1] 65 65 |
123 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | [2] 49 49, 51 |
124 | Diltiazem (Synonym: Dilt-CD (TN)) | [1] Diltiazem Diltiazem (Synonym: Diltiazem CD) | [3] D00616
D00616
(Name: Dilt-CD (TN)),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 58, 86 |
125 | Diltiazem Gel 2% (Synonym: Dilt-CD (TN)) | [1] Diltiazem Diltiazem (Synonym: Diltiazem CD) | [3] D00616
D00616
(Name: Dilt-CD (TN)),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
126 | Diltiazem Hydrochloride (Synonym: Dilt-CD (TN)) | [1] Diltiazem Diltiazem (Synonym: Diltiazem CD) | [3] D00616
D00616
(Name: Dilt-CD (TN)),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
127 | Duodopa LD/CD 20/5 mg/mL | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
128 | EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells | - | - | - | - | [1] 65 65 |
129 | EF1aS-ADA lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
130 | Engineered humanized monoclonal anti-human CD19 antibody. | - | - | - | - | [1] 46 46 |
131 | Engineered humanized monoclonal anti-human CD19 antibody. Lot Numbers: 1-FIN-1588 (9.6mg/ml) | - | - | - | - | [1] 46 46 |
132 | ER CD-LD | - | - | - | - | [1] 6 6 |
133 | Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector | - | - | - | - | [1] 65 65 |
134 | Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA. | - | - | - | - | [1] 36 36 |
135 | Fc- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | [3] 11 11, 62, 109 |
136 | G1XCGD transduced CD34+ cells | - | - | - | - | [1] 65 65 |
137 | Gene-Transduced Autologous CD34+ Stem Cells | - | - | - | - | [1] 65 65 |
138 | Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101) | - | - | - | - | [1] 65 65 |
139 | Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101) | - | - | - | - | [1] 65 65 |
140 | Genetic: Infusion of autologous EFS-ADA LV CD34+ cells | - | - | - | - | [1] 65 65 |
141 | GSK2018682 CD2 Capsule | - | - | - | - | [1] 13 13 |
142 | GSK2018682 CD3 micronised Tablet | - | - | - | - | [1] 13 13 |
143 | GSK2018682 CD3 non-micronised Tablet | - | - | - | - | [1] 13 13 |
144 | GSK2018682 CD3 non-micronised Tablet in fed state | - | - | - | - | [1] 13 13 |
145 | Human monoclonal antibody directed against CD20 on B-cells | - | - | - | - | [1] 46 46 |
146 | Humanised anti-CD 20 antibody | - | - | - | - | [1] 46 46 |
147 | Humanised anti-CD4 IgG1 monoclonal | - | - | - | - | [1] 46 46 |
148 | Humanized recombinant IgG4 monoclonal antibody against CD-127 | - | - | - | - | [1] 97 97 |
149 | HuMax-CD20 | [1] Ofatumumab Ofatumumab (Synonym: HuMax-CD20) | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 13 13, 46 |
150 | HUMAX-CD38 | - | - | - | - | [2] 28 28, 63 |
151 | HuMax-CD38, 3003-005 | - | - | - | - | [1] 28 28 |
152 | HuMax-CD4 | - | - | - | - | [1] 46 46 |
153 | Indium 111-radiolabelled anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 |
154 | Indium 111 labelled Anti-CD66 | [1] Indium Indium | - | - | - | [1] 28 28 |
155 | INEBILIZUMAB (Synonym: Inebilizumab-cdon) | [1] Inebilizumab Inebilizumab (Synonym: inebilizumab-cdon) | [1] D11757
D11757
(Name: Inebilizumab-cdon) | [1] CD19 CD19 💬 | [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 11 11, 13, 51, 300 |
156 | Intravitreal autologous CD34+ cells | - | - | - | - | [1] 90 90 |
157 | IPX203 ER CD-LD | - | - | - | - | [1] 6 6 |
158 | IR CD-LD | - | - | - | - | [1] 6 6 |
159 | IR CD-LD (carbidopa-levodopa) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
160 | IR LD / CD | - | - | - | - | [1] 6 6 |
161 | IR LD/CD | - | - | - | - | [1] 6 6 |
162 | LD/CD | - | - | - | - | [1] 6 6 |
163 | Lentiviral vector transduced CD34+ cells | - | - | - | - | [1] 65 65 |
164 | Levodopa/Carbidopa (LD/CD) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
165 | Methylphenidate (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 6 6, 13, 34, 84, 113, 179, 206 |
166 | Methylphenidate (MPD) (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 6 6 |
167 | Methylphenidate (overencapsulated) (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
168 | Methylphenidate 10mg tablets (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
169 | METHYLPHENIDATE HYDROCHLORIDE (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [2] 6 6, 13 |
170 | Methylphenidate modified release (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
171 | Methylphenidate modified release 20 mg (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
172 | Methylphenidate modified release 30 mg (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
173 | Methylphenidate modified release 40 mg (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [1] Methylphenidate Methylphenidate (Synonym: Metadate CD) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
174 | Methylphenidate, fluoxetin, risperidone (Synonym: METHYLPHENIDATE HYDROCHLORIDE CD) | [3] Fluoxetine Fluoxetine, Methylphenidate (Synonym: Metadate CD), Risperidone | [5] D00326
D00326
,
D00426
,
D00823
,
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999
| [5] DRD2 DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬 | [2] 179 179, 206 |
175 | Miltenyi CD34 Reagent System | - | - | - | - | [1] 60 60 |
176 | Muromonab (Synonym: Muromonab-CD3) | [1] Muromonab Muromonab (Synonym: Anti-CD3) | [1] D05092
D05092
(Name: Muromonab-CD3) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 60 60 |
177 | Muromonab-CD3 | [1] Muromonab Muromonab (Synonym: Anti-CD3) | [1] D05092
D05092
(Name: Muromonab-CD3) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 60 60 |
178 | NI-0401 (anti-CD3 mAB) | [1] Muromonab Muromonab (Synonym: Anti-CD3) | [1] D05092
D05092
(Name: Muromonab-CD3) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 96 96 |
179 | ONO-2160/CD | - | - | - | - | [1] 6 6 |
180 | Open-Label CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid (Synonym: CDCA) | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
181 | Other: CD LFD | - | - | - | - | [1] 96 96 |
182 | Other: CD-TREAT diet | - | - | - | - | [1] 96 96 |
183 | Other: Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 |
184 | Other: Crohn's Disease TReatment-with-EATing diet (CD-TREAT diet) | - | - | - | - | [1] 96 96 |
185 | Other: Diet-CD | - | - | - | - | [1] 96 96 |
186 | Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells | - | - | - | - | [1] 65 65 |
187 | Phase1 : CDED/Modulen™IBD® + Maintenance therapy | - | - | - | - | [1] 96 96 |
188 | Plerixafor mobilization of autologous CD117 stem cells | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [12] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 299 299 |
189 | RAG1 LV CD34+ cells | - | - | - | - | [1] 65 65 |
190 | Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A | - | - | - | - | [1] 19 19 |
191 | Repair of CDH w/Alloderm | - | - | - | - | [1] 294 294 |
192 | Repair of CDH w/SIS Gold | [1] Gold Gold | - | - | - | [1] 294 294 |
193 | Rescue Medication CDCA 250 mg TID | [1] Chenodeoxycholic acid Chenodeoxycholic acid (Synonym: CDCA) | [1] D00163
D00163
| [1] NR1H4 NR1H4 💬 | [1] Bile secretion Bile secretion 💬 | [1] 263 263 |
194 | Retroviral SF71-gp91phox transduced CD34+ cells | - | - | - | - | [1] 65 65 |
195 | Rituximab (anti-CD20) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 53 53 |
196 | Routine Treatment of CD | - | - | - | - | [1] 96 96 |
197 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | [1] 6 6 |
198 | Standard LD/CD | - | - | - | - | [1] 6 6 |
199 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 |
200 | T-Cell Depleted & CD34+Select/w/StemCell Enriched Product | - | - | - | - | [1] 65 65 |
201 | TL011, anti CD20, for the treatment of rheumatoid arthritis | - | - | - | - | [1] 46 46 |
202 | Transduced CD34+ Cells | - | - | - | - | [1] 285 285 |
203 | Transduced patient CD34+ cells | - | - | - | - | [1] 65 65 |
204 | Yttrium-90 radiolabelled anti-CD66 antibody | [1] Yttrium Y-90 Yttrium Y-90 | - | - | - | [1] 28 28 |
205 | Yttrium90 radiolabelled antiCD66 | [1] Yttrium Y-90 Yttrium Y-90 | - | - | - | [1] 28 28 |